CIPLA Cipla Ltd Product Launches Announcement 2024 - Cipla Approval for Lanreotide Injection Cipla Ltd. receives final approval from USFDA for generic version of Lanreotide Injection for Acromegaly and GEP-NETs treatment..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Cipla Ltd